Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Schauer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Drug Investigation|May 26, 2007
Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with AsthmaTeresa Bracamonte, Uwe Schauer, Andrzej Emeryk, et al.
Dermatology (Basel, Switzerland)|October 4, 2007
Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitisTorsten Zuberbier, Lucie Heinzerling, Thomas Bieber, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 8, 2009
Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneouslyWolfgang Kamin, Matthias Volkmar Kopp, Frank Erdnuess, et al.
BMJ Open Respiratory Research|March 31, 2016
Economic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthmaPeter Brazier, Uwe Schauer, Eckard Hamelmann, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen seasonTobias Feuchtinger, Holger Bartz, Andrea von Berg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Establishment of age-dependent reference values for IgA subclassesUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
European Clinical Respiratory Journal|November 12, 2015
Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisonsUwe Schauer, Karl-Christian Bergmann, Michael Gerstlauer, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adultsUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2002
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJoachim Kuehr, Jens Brauburger, Stefan Zielen, et al.
Clinical Chemistry|October 28, 2003
IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagentsUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Drug Investigation|May 26, 2007
Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with AsthmaTeresa Bracamonte, Uwe Schauer, Andrzej Emeryk, et al.
Dermatology (Basel, Switzerland)|October 4, 2007
Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitisTorsten Zuberbier, Lucie Heinzerling, Thomas Bieber, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 8, 2009
Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneouslyWolfgang Kamin, Matthias Volkmar Kopp, Frank Erdnuess, et al.
BMJ Open Respiratory Research|March 31, 2016
Economic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthmaPeter Brazier, Uwe Schauer, Eckard Hamelmann, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2003
Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen seasonTobias Feuchtinger, Holger Bartz, Andrea von Berg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Establishment of age-dependent reference values for IgA subclassesUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
European Clinical Respiratory Journal|November 12, 2015
Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisonsUwe Schauer, Karl-Christian Bergmann, Michael Gerstlauer, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adultsUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2002
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJoachim Kuehr, Jens Brauburger, Stefan Zielen, et al.
Clinical Chemistry|October 28, 2003
IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagentsUwe Schauer, Frank Stemberg, Christian H L Rieger, et al.
Pageof 2